About ProtoKinetix

Changing lives through cell survival

Iceberg animation

Based on a molecule found in nature and harnessed by a world-class research team, this anti-aging glycopeptide keeps more cells alive longer. It utilizes the same properties that help animals survive in arctic temperatures, and it has the capability to change regenerative medicine forever.

Molecule float

Our vision

With AAGP®, health therapies will become more effective, more affordable and more accessible. We will get closer to cures for conditions such as Type 1 diabetes, macular degeneration, heart disease and stroke. More lives will improve, and more people will get the treatments they deserve.

Picture of a man

Key Milestones

  • 2002
    Initial public offering
  • 2003
    First intellectual property (IP) filing
  • 2005
    Initial application for pipeline research
  • 2010
    Good Manufacturing Practice processing and toxicology study success
  • 2014
    IP second filing and Type 1 diabetes islet transplantation study
  • 2016
    Preclinical validation in Type 1 diabetes and peer reviewed papers
  • 2016
    IP third filing and induced pluripotent stem cells study for macular degeneration
  • 2019
    Preclinical validation in macular degeneration
  • 2020
    Engage Food and Drug Administration for consultation on Investigational Drugs and Devices approval for topical products
  • 2020
    Large-scale bioproduct validation
  • 2020
    First licensing agreement for topical products
  • 2021
    Published phase one clinical results for Type 1 diabetes
  • 2021
    Orphan disease status approval
  • 2021
    Initiate phase one clinical trial for macular degeneration
  • 2022
    Initiate phase two clinical trial for Type 1 diabetes
  • 2022
    Milestone partnership agreement for biological biosimilar production
Explore ProtoKinetix

Research pipeline

We are moving cell survival forward by addressing the health conditions that affect our lives. See where we are today and where we are heading next.

Leadership team

The leaders at ProtoKinetix have a clear vision for the future of the company and for the future of regenerative medicine. Learn more about their backgrounds.